Drug-resistant tuberculosis: a persistent global health concern

M Farhat, H Cox, M Ghanem, CM Denkinger… - Nature Reviews …, 2024 - nature.com
Drug-resistant tuberculosis (TB) is estimated to cause 13% of all antimicrobial resistance-
attributable deaths worldwide and is driven by both ongoing resistance acquisition and …

Transcriptomics for child and adolescent tuberculosis

M Kaforou, C Broderick, O Vito, M Levin… - Immunological …, 2022 - Wiley Online Library
Tuberculosis (TB) in humans is caused by Mycobacterium tuberculosis (Mtb). It is estimated
that 70 million children (< 15 years) are currently infected with Mtb, with 1.2 million each year …

Treatment strategy for rifampin-susceptible tuberculosis

NI Paton, C Cousins, C Suresh, E Burhan… - … England Journal of …, 2023 - Mass Medical Soc
Background Tuberculosis is usually treated with a 6-month rifampin-based regimen.
Whether a strategy involving shorter initial treatment may lead to similar outcomes is …

Impact of COVID-19 on tuberculosis case detection and treatment outcomes in Sierra Leone

S Lakoh, DF Jiba, M Baldeh, O Adekanmbi… - Tropical medicine and …, 2021 - mdpi.com
The COVID-19 pandemic has adversely affected tuberculosis (TB) care delivery in high
burden countries. We therefore conducted a retrospective study to assess the impact of …

Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults

LS Peetluk, FM Ridolfi, PF Rebeiro, D Liu, VC Rolla… - BMJ open, 2021 - bmjopen.bmj.com
Objective To systematically review and critically evaluate prediction models developed to
predict tuberculosis (TB) treatment outcomes among adults with pulmonary TB. Design …

Tuberculosis treatment outcome and predictors in Africa: a systematic review and meta-analysis

MY Teferi, Z El-Khatib, MT Boltena… - International journal of …, 2021 - mdpi.com
This review aimed to summarize and estimate the TB treatment success rate and factors
associated with unsuccessful TB treatment outcomes in Africa. Potentially eligible primary …

Active pulmonary tuberculosis in elderly patients: a 2016–2019 retrospective analysis from an Italian Referral Hospital

F Di Gennaro, P Vittozzi, G Gualano, M Musso, S Mosti… - Antibiotics, 2020 - mdpi.com
Tuberculosis (TB) in the elderly (> 65 years old) has increasingly become a global health
problem. It has long been recognized that older people are vulnerable to developing …

Field and classroom initiatives for portable sequence-based monitoring of dengue virus in Brazil

TÉR Adelino, M Giovanetti, V Fonseca, J Xavier… - Nature …, 2021 - nature.com
Brazil experienced a large dengue virus (DENV) epidemic in 2019, highlighting a
continuous struggle with effective control and public health preparedness. Using Oxford …

Clinical and economic burden of drug-susceptible tuberculosis in Indonesia: national trends 2017–19

D Iskandar, AA Suwantika, IS Pradipta… - The Lancet Global …, 2023 - thelancet.com
Background The global incidence of tuberculosis is decreasing, yet it remains high in
Indonesia. The Indonesian National Tuberculosis Program facilitates mandatory notification …

Clinical pharmacy services for tuberculosis management: a systematic review

D Iskandar, FDA Suryanegara… - Frontiers in …, 2023 - frontiersin.org
Objective: This study aims to systematically review the content and potential effects of
clinical pharmacy services in tuberculosis (TB) care management. Methods: Searches were …